Skip to main content
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: J Orthop Res. 2019 Feb 21;37(6):1310–1317. doi: 10.1002/jor.24209

Figure 2.

Figure 2.

(a) MSCs in culture treated with scAAV-equine-BMP-2, rhBMP-2, and osteogenic media exemplify osteogenic morphologic changes at day 7 following transduction. (b) Morphology Scores: Error bars denote standard deviation from the mean. Letter changes denote significant differences between groups. ScAAV-equine-BMP-2 transduced cells, rhBMP-2 treated cells, and osteogenic control cells appeared significantly more osteogenic than GFP transduced cells and negative controls (p < 0.0001). The morphological changes were evident by day 7.